Abstract:Patient-derived cancer cells (PDCs) and patient-derived xenografts (PDXs) are often used as tumor models, but have many shortcomings. PDCs not only lack diversity in terms of cell type, spatial organization, and microenvironment but also have adverse effects in stem cell cultures, whereas PDX are expensive with a low transplantation success rate and require a long culture time. In recent years, advances in three-dimensional (3D) organoid culture technology have led to the development of novel physiological systems that model the tissues of origin more precisely than traditional culture methods. Patient-derived cancer organoids bridge the conventional gaps in PDC and PDX models and closely reflect the pathophysiological features of natural tumorigenesis and metastasis, and have led to new patient-specific drug screening techniques, development of individualized treatment regimens, and discovery of prognostic biomarkers and mechanisms of resistance. Synergistic combinations of cancer organoids with other technologies, for example, organ-on-a-chip, 3D bio-printing, and CRISPR-Cas9-mediated homology-independent organoid transgenesis, and with treatments, such as immunotherapy, have been useful in overcoming their limitations and led to the development of more suitable model systems that recapitulate the complex stroma of cancer, inter-organ and intra-organ communications, and potentially multiorgan metastasis. In this review, we discuss various methods for the creation of organ-specific cancer organoids and summarize organ-specific advances and applications, synergistic technologies, and treatments as well as current limitations and future prospects for cancer organoids. Further advances will bring this novel 3D organoid culture technique closer to clinical practice in the future.

Artificial tumor matrices and bioengineered tools for tumoroids

Artificial Tumor Matrices and Bioengineered Tools for Tumoroid Generation

Construction of tumor organoids and their application to cancer research and therapy

Engineering of biomaterials for tumor modeling

Tissue engineering concept in the research of the tumor biology.

A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine

Flourishing tumor organoids: History, emerging technology, and application

3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (Adv. Healthcare Mater. 18/2023)

3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy

In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids

Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

Organoids: new frontiers in tumor immune microenvironment research

Tumor-microenvironment-on-a-chip: the construction and application

Advancing cancer research through organoid technology

Engineering a Tumor Microenvironment‐Mimetic Niche for Tissue Regeneration with Xenogeneic Cancer Cells

Tumor organoids: From inception to future in cancer research

A synthetic tumour microenvironment

Reconstruction of tumor microenvironment via in vitro three-dimensional models

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Organoids: approaches and utility in cancer research